Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Summary

The purpose of this study is twofold. First, is to determine whether vancomycin is effective in the early treatment of Biliary Atresia (BA) and Primary Sclerosing Cholangitis (PSC), and if so, by what mechanism. Secondly, to characterize human intestinal microbial communities and their interactions with the host.

Timeline

Start

2010-07

Primary completion

2018-05

Completion

2028-07

Drugs

Indications